| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Advance or stagnation in CNS drug development?
|
Beyer, Katrin
|
|
2010
|
9 |
10 |
p. 956-957
2 p.
|
artikel
|
| 2 |
Chromosome 9p21 in amyotrophic lateral sclerosis in Finland: a genome-wide association study
|
Laaksovirta, Hannu
|
|
2010
|
9 |
10 |
p. 978-985
8 p.
|
artikel
|
| 3 |
Chromosome 9p21 in amyotrophic lateral sclerosis: the plot thickens
|
Daoud, Hussein
|
|
2010
|
9 |
10 |
p. 945-947
3 p.
|
artikel
|
| 4 |
Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study
|
Shatunov, Aleksey
|
|
2010
|
9 |
10 |
p. 986-994
9 p.
|
artikel
|
| 5 |
Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial
|
Shinohara, Yukito
|
|
2010
|
9 |
10 |
p. 959-968
10 p.
|
artikel
|
| 6 |
CNS inflammatory disorders: a larger spectrum in smaller patients
|
Anlar, Banu
|
|
2010
|
9 |
10 |
p. 956-
1 p.
|
artikel
|
| 7 |
Emboli detection in asymptomatic carotid stenosis
|
Imray, Chris HE
|
|
2010
|
9 |
10 |
p. 948-949
2 p.
|
artikel
|
| 8 |
Emboli detection in asymptomatic carotid stenosis
|
Karapanayiotides, Theodoros
|
|
2010
|
9 |
10 |
p. 948-
1 p.
|
artikel
|
| 9 |
Emboli detection in asymptomatic carotid stenosis – Author's reply
|
Markus, Hugh S
|
|
2010
|
9 |
10 |
p. 949-
1 p.
|
artikel
|
| 10 |
Epilepsy must become a higher priority in Europe
|
The Lancet Neurology,
|
|
2010
|
9 |
10 |
p. 941-
1 p.
|
artikel
|
| 11 |
Functional MRI in chronic epilepsy: associations with cognitive impairment
|
Vlooswijk, Marielle CG
|
|
2010
|
9 |
10 |
p. 1018-1027
10 p.
|
artikel
|
| 12 |
Haemodynamic stroke: clinical features, prognosis, and management
|
Klijn, Catharina JM
|
|
2010
|
9 |
10 |
p. 1008-1017
10 p.
|
artikel
|
| 13 |
July, 2010
|
|
|
2010
|
9 |
10 |
p. 955-
1 p.
|
artikel
|
| 14 |
Management of patients with myoclonus: available therapies and the need for an evidence-based approach
|
Dijk, Joke M
|
|
2010
|
9 |
10 |
p. 1028-1036
9 p.
|
artikel
|
| 15 |
Manuela Neumann
|
|
|
2010
|
9 |
10 |
p. 955-
1 p.
|
artikel
|
| 16 |
Memantine for patients with Parkinson's disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial
|
Emre, Murat
|
|
2010
|
9 |
10 |
p. 969-977
9 p.
|
artikel
|
| 17 |
Murat Emre: bringing it all back home
|
Williams, Ruth
|
|
2010
|
9 |
10 |
p. 954-
1 p.
|
artikel
|
| 18 |
Navigating cerebellar ataxias
|
Schmahmann, Jeremy D
|
|
2010
|
9 |
10 |
p. 957-
1 p.
|
artikel
|
| 19 |
News in brief
|
|
|
2010
|
9 |
10 |
p. 958-
1 p.
|
artikel
|
| 20 |
Protecting research participants with impaired decision-making capacity
|
Craven, Rebecca
|
|
2010
|
9 |
10 |
p. 952-953
2 p.
|
artikel
|
| 21 |
Secondary prevention of stroke: can we do better than aspirin?
|
Kumbhani, Dharam J
|
|
2010
|
9 |
10 |
p. 942-943
2 p.
|
artikel
|
| 22 |
TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia
|
Mackenzie, Ian RA
|
|
2010
|
9 |
10 |
p. 995-1007
13 p.
|
artikel
|
| 23 |
Treatment of Lewy-body dementias and psychopathology
|
Marsh, Laura
|
|
2010
|
9 |
10 |
p. 943-945
3 p.
|
artikel
|
| 24 |
Would riluzole be efficacious in the new ALS trial design?
|
Verstraete, Esther
|
|
2010
|
9 |
10 |
p. 949-950
2 p.
|
artikel
|
| 25 |
Would riluzole be efficacious in the new ALS trial design? – Authors' reply
|
Aggarwal, Swati
|
|
2010
|
9 |
10 |
p. 950-951
2 p.
|
artikel
|
Tijdschrift beschrijving